To manage compliance risk in regulated industries, treat AI agents like new employees. Before deployment, the agent must pass the same knowledge assessment a human would take. This quantifies the risk, turning a 'black box' AI into an observable and testable system with a verifiable accuracy score.

OpenAI's health division serves a dual purpose: delivering societal benefits and providing a real-world, high-stakes environment for AI safety research. Problems like scalable oversight (supervising superhuman AI) move from theoretical exercises to practical necessities when models outperform physicians on narrow tasks, creating concrete feedback loops that accelerate safety progress.

To maintain trust, AI in medical communications must be subordinate to human judgment. The ultimate guardrail is remembering that healthcare decisions are made by people, for people. AI should assist, not replace, the human communicator to prevent algorithmic control over healthcare choices.

To gain physician trust, AI companies must move beyond proving their algorithm is accurate. The gold standard is large-scale clinical evidence demonstrating tangible improvements in patient outcomes, treatment rates, and decision-making speed.

MedTech AI companies can speed up regulatory approval by building a trusted, real-time post-market surveillance system. This shifts the burden of proof from pre-market studies to continuous real-world evidence, giving regulators the confidence to approve innovations faster, turning them from blockers into partners.

In high-stakes fields like healthcare, the cost of an AI error is immense. Product leaders must prioritize safety, reliability, and the reproducibility of outcomes. A complete audit trail is non-negotiable, as it enables the reversal of incorrect decisions and ensures accountability.

Society holds AI in healthcare to a much higher standard than human practitioners, similar to the scrutiny faced by driverless cars. We demand AI be 10x better, not just marginally better, which slows adoption. This means AI will first roll out in controlled use cases or as a human-assisting tool, not for full autonomy.

Don't invent an AI governance framework in a vacuum. The most effective approach is to first observe how your existing IT, data, and security governance processes function in practice. This allows you to identify the 'path of least resistance' and overlay new AI-specific concerns onto established workflows.

Dr. Jordan Schlain frames AI in healthcare as fundamentally different from typical tech development. The guiding principle must shift from Silicon Valley's "move fast and break things" to "move fast and not harm people." This is because healthcare is a "land of small errors and big consequences," requiring robust failure plans and accountability.